首页> 美国卫生研究院文献>Environmental Health Perspectives >Mutagenicity testing of diethylene glycol monobutyl ether.
【2h】

Mutagenicity testing of diethylene glycol monobutyl ether.

机译:二甘醇单丁醚的致突变性测试。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mutagenic potential of diethylene glycol monobutyl ether (diEGBE) was examined with a Tier I battery of in vitro assays followed by a Tier II in vivo Drosophila sex-linked recessive lethal assay. The in vitro battery consisted of: the Salmonella mutagenicity test, the L5178Y mouse lymphoma test, a cytogenetics assay using Chinese hamster ovary cells and the unscheduled DNA synthesis (UDS) assay in rat hepatocytes. Results of the Salmonella mutagenicity test, the cytogenetics test, and the rat hepatocyte assay were negative at concentrations up to 20 microL/plate, 7.92 microL/mL, and 4.4 microL/mL, respectively. Toxicity was clearly demonstrated at all high doses. A weak, but dose-related increase in the mutation frequency (4-fold increase over the solvent control at 5.6 microL/mL with 12% survival) was obtained in the L5178Y lymphoma test in the absence of metabolic activation. Results of the mouse lymphoma assay were negative in the presence of the S-9 activation system. The significance of the mouse lymphoma assay were negative in the presence of the S-9 activation system. The significance of the mouse lymphoma assay results were assessed by performing the Tier II sex-linked recessive lethal assay in Drosophila in which the target tissue is maturing germinal cells. Both feeding (11,000 ppm for 3 days) and injection (0.3 microL of approximately 14,000 ppm solution) routes of administration were employed in the Drosophila assay. Approximately 11,000 individual crosses with an equal number of negative controls were performed for each route of administration. diEGBE produced no increase in recessive lethals under these conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:使用第I层体外试验电池,然后进行第II层体内果蝇性连锁隐性致死试验,检查了二甘醇单丁醚(diEGBE)的诱变潜力。体外电池包括:沙门氏菌诱变试验,L5178Y小鼠淋巴瘤试验,使用中国仓鼠卵巢细胞的细胞遗传学测定以及大鼠肝细胞中的非计划DNA合成(UDS)测定。沙门氏菌诱变测试,细胞遗传学测试和大鼠肝细胞分析的结果分别在最高20 microL /板,7.92 microL / mL和4.4 microL / mL时均为阴性。在所有高剂量下均清楚地显示出毒性。在L5178Y淋巴瘤试验中,在没有新陈代谢激活的情况下,获得了微弱但与剂量相关的突变频率增加(在5.6 microL / mL时比溶剂对照增加4倍,存活率为12%)。在存在S-9激活系统的情况下,小鼠淋巴瘤测定的结果为阴性。在存在S-9激活系统的情况下,小鼠淋巴瘤测定的意义为阴性。通过在果蝇中进行Tier II性连锁隐性致死试验来评估小鼠淋巴瘤试验结果的重要性,在该试验中目标组织正在成熟的生殖细胞中。在果蝇试验中均采用了喂食(11,000 ppm,持续3天)和注射(0.3 µL,约14,000 ppm溶液)的给药途径。每种给药途径均进行了约11,000个单独的杂交,阴性对照数量相同。在这种情况下,diEGBE的隐性致死率没有增加。(摘要截断为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号